Login / Signup

Prolonged ICU Stay in Severe and Critically-Ill COVID-19 Patients Who Received Convalescent Plasma Therapy.

Bambang Pujo SemediNadya Noor RamadhaniaBetty Agustina TambunanSiprianus Ugroseno Yudho BintoroSoedarsono SoedarsonoCita Rosita Sigit Prakoeswa
Published in: Critical care research and practice (2022)
The length of stay of patients in the convalescent plasma group was significantly longer than the control group. There was no effect of convalescent plasma in ICU mortality and no improvement was observed in terms of oxygen support requirements.
Keyphrases
  • intensive care unit
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • sars cov
  • prognostic factors
  • risk factors
  • type diabetes
  • stem cells
  • coronary artery disease
  • early onset